Some new certainty and continued uncertainty in latest state and federal marijuana reform developments

After a lot of uncertainty about when adult-use sales would begin in Ohio, some timeline certainty emerged yesterday in the Buckeye State: “Ohio Cannabis Dispensaries Will Start Adult-Use Sales Aug. 6.”  Here are some of the particulars:

Ohio will be the 21st state to launch adult-use cannabis sales when licensed dispensaries open their doors to those 21 and older at 10 a.m. Aug. 6.

The Ohio Division of Cannabis Control (DCC) hasn’t officially issued dual-use certificates of operation—allowing existing dispensaries to serve both medical patients and adult-use customers—to store owners just yet, but the division plans to make a formal announcement Aug. 5, a Department of Commerce spokesperson told Cannabis Business Times….

Ohio’s imminent launch represents a catalyst for the cannabis industry: Ohio will be the fourth most-populated state to commence adult-use sales after California, Illinois and New York.  Ohio is also the first to roll out an adult-use program since Maryland did so on July 1, 2023.

In addition, millions of adults 21 years and older residing in bordering Pennsylvania, Indiana, Kentucky and West Virginia—who don’t have access to adult-use cannabis in their home states—will now live within driving distance of licensed and regulated cannabis products.

Meanwhile, there is still continued uncertainty concerning the timeline for potential federal refrom in the form of rescheduling. But, as reported in this Marijuana Moment article, a collection of US Senators are urging the Drug Enforcement Administration  to “promptly finalize” the proposed rule to reschedule marijuana from Schedule I to Schedule III.  Here are the basics:

In a letter sent to Attorney General Merrick Garland and DEA Administrator Anne Milgram on Friday, Schumer and Sens. Cory Booker (D-NJ), Ron Wyden (D-OR) and others implored the administration to follow through on a proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), as the Justice Department formally proposed in May.

“The proposed rule to reclassify marijuana to schedule III recognizes the medical benefits of marijuana, will improve access for studying the health effects of short and long-term cannabis use, and will provide relief to cannabis businesses that continue to navigate a patchwork regulatory system to conduct legal business,” they said.

The full letter from the seven Senators (all Deomocrats) is available at this link.